OTO-201 for Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the safety and tolerability of two dose levels of
OTO-201, placebo and sham when administered intra-operatively in pediatric subjects with
bilateral middle ear effusion who require tympanostomy tube placement.